Ledger.Open graph →
SEC Form D · filed January 23, 2019

Alcresta Therapeutics, Inc

Offering
$25.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARREN, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

William Scheinler · Warren, NJExecAnastasios Konidaris · Warren, NJExec · DirectorAlexey Margolin · Warren, NJDirectorStephen Kraus · Warren, NJDirectorSteve Dubin · Warren, NJDirectorGarheng Kong · Menlo Park, CADirectorJonathan Hong · Miami, FLExecDavid Kownator · Miami, FLDirectorAdib Mattar · Miami, FLDirectorTheresa Mohan · Miami, FLDirectorMatt Lindenberger · Miami, FLExec · DirectorAri Ojalvo · Miami, FLDirectorCharles T. Holland · NEW YORK, NYDirectorHoward Mergelkamp · Cromwell, CTDirectorFiona P. Mulhall · Dublin, IrelandExec · DirectorBrian P. Murphy · Darien, CTExecStephen Pearce · London, United KingdomDirectorGlynn Phillips · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗